Rephonic
Artwork for Hematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Multiple Myeloma
Chronic Lymphocytic Leukemia
CAR T-Cell Therapy
Follicular Lymphoma
Bispecific Antibodies
Non-Hodgkin Lymphoma
Venetoclax
BTK Inhibitors
Myelofibrosis
Clinical Trials
Acute Myeloid Leukemia
Immune Thrombocytopenia
Diffuse Large B-Cell Lymphoma
CAR T Therapy
Chronic Myeloid Leukemia
Mantle Cell Lymphoma
Daratumumab
FDA Approval
Cytokine Release Syndrome
Tyrosine Kinase Inhibitors

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

PublishesTwice weeklyEpisodes545Founded18 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Hematologic Oncology Update

Latest Episodes

Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Manali Kamdar, Dr Tycel Phillips and Dr Jason Westin, moderated by Dr Abramson, including the following topics:

• Introduction (0:00)

• Chimeric Antigen Receptor (CAR) T-Cell Ther... more

Featuring perspectives from Prof Claire Harrison and Dr Raajit K Rampal, including the following topics:

• Introduction (0:00)

• The Biopathophysiology of Myelofibrosis (MF) (2:19)

• Current and Future Clinical Decision-Making in the Absence of Seve... more

YouTube

Featuring perspectives from Dr Jeremy S Abramson, Dr John N Allan, Dr Bita Fakhri, Dr Shuo Ma and Dr Mazyar Shadman, moderated by Dr Abramson, including the following topics:

• Introduction (0:00)

• Current and Future Role of Continuous Bruton Tyros... more

YouTube

Featuring perspectives from Dr Beth Faiman, Dr Natalie S Callander, Dr Hans Lee and Dr Mary Steinbach, moderated by Dr Callander, including the following topics:

• Introduction (00:00)

• Role of Chimeric Antigen Receptor T-Cell Therapy in Relapsed/R... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Blood Cancer Talks
Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Blood Podcast
Blood PodcastAmerican Society of Hematology
The Hematologist
The HematologistThe Hematologist

Recent Guests

Susmita Apuri
General medical oncologist, case presenter
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Steven Fred Divers
General medical oncologist, case presenter
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Priya Rudolph
Case presenter and clinician
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Beth Faiman
Discussions expert on hematologic malignancies
Cleveland Clinic
Episode: For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress
Mary Steinbach
Hematology-focused clinician
University of Utah Huntsman Cancer Center
Episode: For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress
Hans Lee
Medical oncologist specializing in myeloma
Sarah Cannon Cancer Center
Episode: For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress
Dr. Mazyar Shadman
Dr. Mazyar Shadman, Fred Hutchinson Cancer Center, University of Washington in Seattle
Fred Hutchinson Cancer Center / University of Washington
Episode: Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1
Mazyar Shadman
Expert in CLL research and treatment, discussed cases and trial data
Fred Hutchinson Cancer Center, University of Washington
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Daniel Ermann
Oncologist presenting a case with upfront management in CLL
Huntsman Cancer Institute, University of Utah
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2

Host

Dr. Neil Love
Lead interviewer and host across multiple series and episodes, focused on hematology-oncology topics and CME-driven education.

Reviews

4.6 out of 5 stars from 133 ratings
  • A favorite of mine

    Podcast Addict
    5
    ZGDave
    a month ago
  • A debt of gratitude that cannot be repaid

    That is how I feel about Dr Neil Love and his tireless work in continuing medical education for everyone in the medical field. These podcasts and discussions contained are informative, thought provoking and provide and excellent in depth but quick update in the rapidly ever-changing field of Hematology-Oncology.

    Apple Podcasts
    5
    Bongir
    United States3 years ago
  • Excellent content

    Always informative, always applies to those of us on the ground making difficult daily decisions on management in the community. Often with limited resources.

    Apple Podcasts
    5
    ZomBucker
    United States4 years ago
  • Excellent up to date reviews.

    I

    Apple Podcasts
    5
    IanMack5000
    United States15 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Strong guest expertise and case-driven discussions that translate to clinic work.
Consistently up-to-date with ASH data and real-world takeaways.
High quality, practical updates for everyday decision-making in hematology-oncology.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#34
Argentina/Science
Apple Podcasts
#173
Singapore/Science
Apple Podcasts
#188
Saudi Arabia/Science
Apple Podcasts
#218
Taiwan/Science
Apple Podcasts
#231
India/Science
Apple Podcasts
#242
South Korea/Science

Talking Points

Recent interactions between the hosts and their guests.

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Q: Can you comment on the risk of ventricular arrhythmias with different BTK inhibitors and how you approach cardiac risk in treatment selection?
Ventricular arrhythmias are more associated with some BTK inhibitors than others; careful cardiac optimization and cardio-oncology collaboration are essential, and some agents (e.g., acalabrutinib, zanubrutinib) may have more favorable cardiac profiles in high-risk patients, though individual patient factors guide choice.
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Q: What is your approach to choosing between Venetoclax-based regimens and BTK inhibitors in elderly patients with bulky disease and comorbidities?
In older patients with comorbidities, balancing efficacy with toxicity is crucial; BTK inhibitors may be favored for continuous therapy if well tolerated, while fixed-duration Venetoclax-based regimens might be appropriate when MRD status and patient preference support stopping therapy earlier.
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Q: For patients with complex karyotype, how do you weigh TP53 status against complex abnormalities when choosing therapy?
TP53 aberrations remain a key high-risk feature driving consideration for continuous BTK inhibitor therapy, while complex karyotype alone is less determinative; decisions should integrate TP53 status, IGHV, and overall risk with emerging data on how complex karyotype interacts with novel agents.
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Q: How do you think MRD status will influence future trial design and decision-making for fixed-duration therapies in CLL?
MRD is likely to guide decisions in fixed-duration regimens, potentially shortening or extending therapy based on MRD negativity, but its role as a universal surrogate for PFS is not settled and may depend on the treatment context and patient risk profile.
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
Q: What did the Paradigm Trial at ASH show, and what is its relevance for upfront therapy in younger patients?
Paradigm suggested that Aza- Venetoclax-based approaches using A's of N could enable some transplant-eligible patients to reach transplant with potentially better event-free survival and less hospitalization burden compared to intensive chemotherapy, supporting interest in triplet strategies for fit younger patients.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Hematologic Oncology Update

What is Hematologic Oncology Update about and what kind of topics does it cover?

A clinically focused, expert-driven series that features one-on-one conversations with hematology-oncology specialists. Episodes center on the latest data and practice implications from ASH meetings, pivotal trials, and emerging therapies (BTK inhibitors, CELMoDs, ITP treatments, bispecific antibodies, CAR-T). Real-world considerations— MRD testing, sequencing of therapies, transplant timing, and toxicity management—are threaded through practical case discussions. Listeners can expect in-depth, practice-oriented insights from leading clinicians affiliated with major cancer centers, with a strong emphasis on translating trials into community care. Notably, the format often blends trial design explanations with real-world anecdotes to illustr... more

Where can I find podcast stats for Hematologic Oncology Update?

Rephonic provides a wide range of podcast stats for Hematologic Oncology Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Hematologic Oncology Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Hematologic Oncology Update get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Hematologic Oncology Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Hematologic Oncology Update?

Rephonic provides comprehensive predictive audience data for Hematologic Oncology Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Hematologic Oncology Update have?

To see how many followers or subscribers Hematologic Oncology Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Hematologic Oncology Update?

These podcasts share a similar audience with Hematologic Oncology Update:

1. Two Onc Docs
2. Blood Cancer Talks
3. Blood Podcast
4. Gastrointestinal Cancer Update
5. The Hematologist

How many episodes of Hematologic Oncology Update are there?

Hematologic Oncology Update launched 18 years ago and published 545 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Hematologic Oncology Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Hematologic Oncology Update?

Rephonic pulls ratings and reviews for Hematologic Oncology Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Hematologic Oncology Update?

Rephonic provides full transcripts for episodes of Hematologic Oncology Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Hematologic Oncology Update?

Recent guests on Hematologic Oncology Update include:

1. Susmita Apuri
2. Steven Fred Divers
3. Priya Rudolph
4. Beth Faiman
5. Mary Steinbach
6. Hans Lee
7. Dr. Mazyar Shadman
8. Mazyar Shadman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days